Results 221 to 230 of about 15,566 (231)

Impact of CYP3A5 Genotype on Tacrolimus Versus Midazolam Clearance in Renal Transplant Recipients: New Insights in CYP3A5-Mediated Drug Metabolism

Pharmacogenomics, 2013
Hylke De Jonge, Henriette De Loor, Yves Vanrenterghem   +2 more
exaly  

CYP3A5*9 Allele

2020
openaire   +1 more source

CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population

Cancer Letters, 2005
Shintaro Narita, Takamitsu Inoue, Yohei Horikawa   +2 more
exaly  

Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes

European Journal of Clinical Pharmacology, 2018
Kyoichi Wada, Sachi Matsuda, Akira Oita   +2 more
exaly  

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

Frontiers in Pharmacology, 2020
Teun Van Gelder, Soufian Meziyerh, Jesse J Swen   +2 more
exaly  

CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations

European Journal of Clinical Pharmacology, 2003
Qingyu Zhou, Edmund J D Lee
exaly  

Functionally defective or alteredCYP3A4andCYP3A5single nucleotide polymorphisms and their detection with genotyping tests

Pharmacogenomics, 2005
Su-Jun Lee, Joyce A Goldstein
exaly  

Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects

European Journal of Clinical Pharmacology, 2008
Kyoung-Ah Kim, Pil-Whan Park, Ji-Young Park   +2 more
exaly  

CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine

Pharmacogenomics Journal, 2008
Juliane Bolbrinker, Friedo W Dekker, Joachim Beige   +2 more
exaly  

Ethnic differences in the distribution ofCYP3A5gene polymorphisms

Xenobiotica, 2006
Delphine Allorge, Jean-Marc Lo-Guidice, Florence Migot-Nabias   +2 more
exaly